SubjectID,SiteID,ExperimentID,VisitID,SegmentID,Demographics_dDEMOG_ANTIEPS_START,Demographics_dDEMOG_CUR_ANTIPSYCHOTIC_START,Demographics_dDEMOG_FIRST_ANTIPSYCHOTIC_START,Demographics_nDEMOG_AGE_HOSPITALIZATION,Demographics_nDEMOG_AGE_ONSET_PREDROMAL,Demographics_nDEMOG_AGE_ONSET_PSYCHOTIC,Demographics_nDEMOG_ANTIDEPRESSANT,Demographics_nDEMOG_ANTIEPS,Demographics_nDEMOG_BMI,Demographics_nDEMOG_CURRENT_ANTIPSYCHOTIC,Demographics_nDEMOG_CUR_AGE,Demographics_nDEMOG_DIAGNOSIS,Demographics_nDEMOG_ETHNICITY,Demographics_nDEMOG_FIRST_ANTIPSYCHOTIC_AGE,Demographics_nDEMOG_HEIGHT,Demographics_nDEMOG_HOSPITALIZATIONS_NUMBER,Demographics_nDEMOG_MARITAL,Demographics_nDEMOG_MOOD,Demographics_nDEMOG_RACE,Demographics_nDEMOG_RELATIVE_PSYCHOSIS,Demographics_nDEMOG_SUICIDE_ATTEMPTS,Demographics_nDEMOG_TYPE,Demographics_nDEMOG_WEIGHT,Demographics_sDEMOG_ANTIDEPRESSANT_DOSE,Demographics_sDEMOG_ANTIDEPRESSANT_DRUG,Demographics_sDEMOG_ANTIEPS_DOSE,Demographics_sDEMOG_ANTIEPS_DRUG,Demographics_sDEMOG_BP,Demographics_sDEMOG_CUR_ANTIPSYCHOTIC_DOSE,Demographics_sDEMOG_CUR_ANTIPSYCHOTIC_DRUG,Demographics_sDEMOG_FIRST_ANTIPSYCHOTIC,Demographics_sDEMOG_FIRST_ANTIPSYCHOTIC_DRUG,Demographics_sDEMOG_GENDER,Demographics_sDEMOG_HANDEDNESS,Demographics_sDEMOG_MOOD_DOSE,Demographics_sDEMOG_MOOD_DRUG
000966724198,0009,93441,1,1,.,.,.,.,.,.,.,.,32.9,.,54,2,0,.,62,.,1,.,5,.,.,.,180,,,,,124/68,,,0,,F,R,,
001312253228,0009,93441,1,1,.,01/01/1995,02/01/1990,27,24,27,0,0,26,1,47,1,0,27,75,20,5,0,5,1,0,1,205,,,,,141/92,450,Clozaril,1,Thorazine,M,R,,
001312445276,0009,93441,1,1,.,.,.,.,.,.,.,.,23.8,.,29,2,0,.,67,.,5,.,3,.,.,.,152,,,,,135/78,,,0,,F,R,,
